Sea You at Fetch Long Beach
Logo Image
|Videos|September 2, 2021

Challenges for pet owners with canine lymphoma treatments

Kansas City

In an interview with dvm360®, Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses reasons why some pet owners decline to have their dogs provided with treatment for lymphoma and how veterinarians can help clients address these challenges.

In an interview with dvm360®, Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses multiple reasons why some pet owners decline to have their dogs provided with treatment for lymphoma and how veterinarians can help clients address these challenges.

View the video for the entire discussion. The following is a partial transcript:

Sue Ettinger, DVM, DACVIM (Oncology): The No. 1 reason ends up being cost, especially if they don’t have pet insurance. [Additionally, there is] the fear of chemotherapy side effects, even though, as we’ll go through with the owner, that chemotherapy is very well tolerated, a lot of people have preconceived notions that their pet isn’t going to tolerate it.

Related to this article

View more
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Read more
Laverdia now available for purchase for dogs with lymphoma
Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
Read more